Individualizing Gentamicin Dosage Regimens in Burn Patients with Gram-Negative Septicemia: A Cost–Benefit Analysis (Q39650272)
scientific article published on March 1, 1979
Language:
(P31) (Q13442814)
(P304) 267-272
(P407) (Q1860)
(P433) 3
(P478) 68
(P577) Thursday, March 1, 1979
(P921) (Q632006)
(Q183134)
(Q422482)
(Q942582)
(Q1110041)
(Q7180763)
(P953) https://api.elsevier.com/content/article/PII:S0022354915425237?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0022354915425237?httpAccept=text/plain
(P1433) (Q3186933)
(P1476) "Individualizing Gentamicin Dosage Regimens in Burn Patients with Gram-Negative Septicemia: A Cost–Benefit Analysis" (language: en)
"Individualizing gentamicin dosage regimens in burn patients with gram-negative septicemia: a cost--benefit analysis" (language: en)
(P2093) J. L. Bootman
A. I. Wertheimer
D. Zaske
C. Rowland
(P2860) (Q77427805)
(Q35841770)
(Q54235060)
(Q67779622)
(Q45218756)
(Q67281381)
(Q36809824)
other details
description scientific article published on March 1, 1979

External Links